check_circleStudy Completed

Bacterial Infections

Bayer Identifier:

Trial_0570

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Ciprofloxacin oral suspension administered for 3 days versus ciprofloxacin oral suspension administered for 5 days in children and juveniles for the treatment of Shigella dysenteriae type one dysentery

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
253
Trial Dates
May 1996 - June 2000
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

A prospective, controlled, randomized, double-blind, multicentre study comparing the efficacy and safety of ciprofloxacin oral suspension administered for 3 days (short course) versus ciprofloxacin oral suspension administered for 5 days (standard course) in children and juveniles for the treatment of Shigella dysenteriae type one dysentery (BAY q 3939/582002)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.